Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study.

Jing LiJu GaoAnsheng LiuWei LiuHao XiongChangda LiangYongjun FangYunpeng DaiJingbo ShaoHui YuLingzhen WangLi WangLiangchun YangMei YanXiaowen ZhaiXiaodong ShiXin TianXiuli JuYan ChenJing WangLeping ZhangHui LiangSen ChenJingrong ZhangHaixia CaoJiao JinQun HuJunlan WangYilin WangMin ZhouYueqin HanRong ZhangWeihong ZhaoXiaoli WangLimin LinRuidong ZhangChao GaoLiting XuYuanyuan ZhangJia FanYing WuWei LinJiaole YuPeijing QiPengli HuangXiao-Xia Peng Yaguang PengTianyou WangHuyong Zhengnull null

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

HHT is an alternative combination regimen for childhood AML. The effects of ATRA-based maintenance are comparable with those of cytarabine-based maintenance therapy.

Keyphrases

acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
randomized controlled trial
early life
childhood cancer
high dose
stem cells
cell therapy